Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study

European Urology Focus - Tập 5 - Trang 1007-1013 - 2019
T. Steuber1, C. Jilg2, P. Tennstedt1, A. De Bruycker3, D. Tilki1,4, K. Decaestecker5, T. Zilli6, B.A. Jereczek-Fossa7, U. Wetterauer2, A.L. Grosu8, W. Schultze-Seemann2, H. Heinzer1, M. Graefen1, A. Morlacco9, R.J. Karnes9, P. Ost3
1Martini Clinic Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
2Department of Urology, Albert Ludwig University Hospital, Freiburg, Germany
3Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
4Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
5Department of Urology, Ghent University Hospital, Ghent, Belgium
6Department of Radiotherapy, Geneva University Hospital, Geneva, Switzerland
7University of Milan and European Institute of Oncology, Milan Italy
8Department of Radiation Oncology, Albert Ludwig University hospital, Freiburg, Germany
9Department of Urology, Mayo Clinic, Rochester, MN, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

European Urology Focus

Tập 5

1007-1013

Thông tin tác giả